Sources | Names Used |
---|---|
CTRPv2 | decitabine:navitoclax (2:1 mol/mol) |
PharmacoGx | decitabine:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | LA16c-431H6.6 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
mRNA | RNF219 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
mRNA | ZNRF1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
mRNA | ADAMTS14 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0007 |
mRNA | SRP9 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
mRNA | ZNF747 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |
mRNA | ACRV1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |
mRNA | NUP133 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |
mRNA | MGRN1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |
mRNA | PITHD1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |